Leadership Overview
Torrent Pharma has 7 executives leading key functions including strategy, technology, operations, finance, quality assurance, and management.
Driven by scientific excellence, Torrent Pharma is dedicated to developing high-quality, affordable medicines for patients worldwide, maintaining a strong international presence and leadership across key therapeutic areas.
Driven by scientific excellence, Torrent Pharma is dedicated to developing high-quality, affordable medicines for patients worldwide, maintaining a strong international presence and leadership across key therapeutic areas.
Leadership Roles at Torrent Pharma
Ankur Jain - Chief Executive Officer
Ankur Jain, the Chief Executive Officer at Torrent Pharma, directs the company's overarching strategy and global operations. Jain's leadership guides Torrent Pharma's position as a leading pharmaceutical enterprise in India with a significant international footprint. This executive oversees the strategic expansion into key therapeutic areas, including cardiovascular health, central nervous system disorders, gastro-intestinal care, and cosmo-dermatology, while also driving growth in diabetology, pain management, and oncology. Jain ensures the company's commitment to research and development remains central, fostering an environment of innovation and scientific excellence. The Chief Executive Officer's vision propels the development of high-quality, affordable medicines, aligning operational execution with the company's mission to serve patients globally. Ankur Jain's strategic direction is critical for maintaining market leadership and achieving sustained growth across all business segments.
Joseph Del Buono - Chief Financial Officer
Joseph Del Buono, the Chief Financial Officer at Torrent Pharma, directs the company's financial strategy, resource allocation, and fiscal management. Del Buono's oversight ensures robust financial health, enabling sustained investment in research and development and the expansion of global operations. The Chief Financial Officer manages capital deployment, drives profitability initiatives, and ensures compliance with all financial regulations across Torrent Pharma's international markets. This executive's expertise is critical for supporting the company's growth trajectory and its commitment to developing affordable medicines. Del Buono's financial acumen provides the foundation for Torrent Pharma's scientific endeavors and its market leadership. Joseph Del Buono's stewardship of financial resources is integral to the company's long-term success and its ability to serve patients worldwide.
Sudhir Menon - Executive Director & Chief Financial Officer
Sudhir Menon, the Executive Director & Chief Financial Officer at Torrent Pharma, provides dual leadership in financial governance and strategic direction. Menon's role involves overseeing the company's comprehensive financial operations, including budgeting, forecasting, and investment strategies, ensuring fiscal stability and growth. The Executive Director & Chief Financial Officer collaborates closely with other senior leaders to align financial planning with the company's ambitious goals in research and development and market expansion. Menon's financial expertise supports the continuous improvement of advanced infrastructure and the cultivation of a highly skilled scientific workforce dedicated to producing high-quality, affordable medicines. This dual role ensures that financial decisions directly contribute to Torrent Pharma's mission of global patient care. Sudhir Menon's integrated leadership is vital for navigating complex financial landscapes and driving sustainable value.
Hasmukh Patel - Chief Operating Officer
Hasmukh Patel, the Chief Operating Officer at Torrent Pharma, manages the day-to-day operational execution across the company's diverse business units. Patel's responsibilities encompass optimizing manufacturing efficiency, ensuring supply chain integrity, and overseeing the seamless integration of operations in both domestic and international markets. The Chief Operating Officer drives the implementation of best practices in production and quality control, directly supporting the development of high-quality, affordable medicines. Patel's leadership ensures that Torrent Pharma's advanced infrastructure operates at peak performance, enabling the scientific workforce to focus on innovation. This executive's operational oversight is crucial for maintaining the company's strong market presence and its commitment to delivering essential treatments. Hasmukh Patel's focus on operational excellence underpins Torrent Pharma's global reach and its reputation for reliability.
Geena Malhotra - Chief Technology Officer
Geena Malhotra, the Chief Technology Officer at Torrent Pharma, architects the company's technological infrastructure and digital transformation initiatives. Malhotra's role is pivotal in leveraging advanced technology to enhance research and development capabilities, streamline manufacturing processes, and improve patient access to medicines. Overseeing the integration of cutting-edge scientific tools and data analytics, the Chief Technology Officer ensures Torrent Pharma maintains its competitive edge in a rapidly evolving pharmaceutical landscape. Malhotra's strategic focus includes bolstering the company's advanced infrastructure, supporting the highly skilled scientific workforce in their pursuit of innovative drug development. This leadership ensures operational efficiency and the robust development of high-quality, affordable treatments. Geena Malhotra's technological vision directly supports the company's mission to deliver impactful healthcare solutions worldwide.
Vidyasagar Gotpagar - Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations )
Vidyasagar Gotpagar, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) at Torrent Pharma, spearheads critical quality assurance functions across contract manufacturing operations. Gotpagar's mandate involves rigorous monitoring at various locations to ensure adherence to the highest standards of pharmaceutical production and compliance. This executive's focus on quality assurance is paramount to delivering high-quality, affordable medicines, directly supporting Torrent Pharma's reputation for excellence. Gotpagar ensures that all contract manufacturing processes align with the company's stringent quality protocols and regulatory requirements. The meticulous oversight provided by the Executive LLM - Quality Assurance is essential for maintaining the integrity of the supply chain and the efficacy of the final products. Vidyasagar Gotpagar's dedication to quality underpins the company's commitment to patient safety and therapeutic success.
Akash Vimal - Senior Executive Manager
Akash Vimal, the Senior Executive Manager at Torrent Pharma, contributes significantly to the strategic execution and operational management of key business initiatives. Vimal's role involves coordinating cross-functional teams to drive project success and ensure alignment with the company's broader objectives in pharmaceutical development and market penetration. The Senior Executive Manager plays a crucial part in optimizing resource allocation and enhancing operational efficiencies across various departments. Vimal's contributions support the company's commitment to scientific excellence and the development of high-quality, affordable medicines for patients globally. This leadership position is instrumental in translating strategic plans into tangible outcomes, reinforcing Torrent Pharma's market leadership. Akash Vimal's management expertise is vital for the sustained growth and operational integrity of the organization.
Explore Leadership Teams in Manufacturing
Founded in 1885, Boehringer Ingelheim is a pharmaceutical company which concentrates on the development of human pharmaceuticals, biopharmaceuticals, chemicals, and animal health products.
Company Leadership EM
RP
YL
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The companys lead product is Translarna (ataluren), for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.
Company Leadership
JB
LG
Tilray was established in 2018 in British Columbia, Canada. They specialize in the research, cultivation, production and distribution of medical cannabis and cannabinoids.
Company Leadership AF
SS
Chemipharm is the only company selling directly to 100% of the reachable pharmacies and hospitals in Egypt. Chemipharm's distribution network includes: 12 branches allover Egypt. 100 fixed routes every day. Total 150 visiting all the pharmacies all over the country. Latest News : PROFILE Company Profile: Chemipharm was founded in 1972 by Dr. Gamal Kamel as the first private sector importer of pharmaceutical products in Egypt. Over the last 35 years, Chemipharm has developed and maintained an invaluable reputation as Egypt's most respectable and high standards pharmaceutical distributor. In 2003, based on the company's continuous growth, Chemipharm has established its own manufacturing facility in the 6th of October Industrial Zone. Plant was designed by Pharma Consult. The modern GMP plant produces pharmaceutical products of all major forms (tablets, capsules, syrups and ointments). Presently Chemipharm is constructing a new sterile area to produce ampoules, eye drops and antibiotics. The company's strategy is based on continuous improvement and growth.
Company Leadership KK
DO
NM
Frequently Asked Questions Regarding Torrent Pharma Top Executives and Leadership Team
